National Health Act 1953 Determination under subsection 84AG(1) Drugs in the same therapeutic group (No. PB 80 of 2009) (Cth)

Case
No judgment structure available for this case.

COMMONWEALTH OF AUSTRALIA

Instrument number PB 80 of 2009

Determination under subsection 84AG(1) of the National Health Act 1953

I, LINDA JACKSON, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under subsection 84AG(1) of the National Health Act 1953.

Dated   28 August                   2009

LINDA JACKSON

Assistant Secretary

Pharmaceutical Evaulation Branch

Department of Health and Ageing

Determination – Drugs in same therapeutic group

1.      Commencement

This instrument commences on 1 September 2009.

2.      Repeal

PB 60 of 2007 is repealed.

3.      Definitions

In this instrument:

ACE inhibitor group means the Angiotensin converting enzyme inhibitor group;

ATRA group means the Angiotensin II receptor antagonist group;

CCB group means the Dihydropyridine calcium-channel blocker group;

H2RA group means the H2 receptor antagonist group;

PPI group means the Proton pump inhibitor group;

Statins group  means the HMG Co-A reductase inhibitor group;

Statins-HP group  means the HMG Co-A reductase inhibitor higher potency group.

4.      Therapeutic group

For paragraph 84AG(1)(a), the HMG Co-A reductase inhibitor higher potency group is a therapeutic group.

Note: Therapeutic groups have also been prescribed by regulation 9AAD of the National Health (Pharmaceutical Benefits) Regulations 1960

5.      Drugs in therapeutic group

For paragraph 84AG(1)(b), a listed drug mentioned in Schedule 1 in all circumstances is in the same therapeutic group mentioned for the listed drug as another listed drug for which that therapeutic group is also mentioned in

Schedule 1.

Schedule 1   Drugs in therapeutic groups

Listed drug Group
Captopril ACE inhibitor group
Enalapril ACE inhibitor group
Fosinopril ACE inhibitor group
Lisinopril ACE inhibitor group
Perindopril ACE inhibitor group
Quinapril ACE inhibitor group
Ramipril ACE inhibitor group
Trandolapril ACE inhibitor group
Candesartan ATRA group
Eprosartan ATRA group
Irbesartan ATRA group
Olmesartan ATRA group
Telmisartan ATRA group
Valsartan ATRA group
Amlodipine CCB group
Felodipine CCB group
Lercanidipine CCB group
Nifedipine CCB group
Cimetidine H2RA group
Famotidine H2RA group
Nizatidine H2RA group
Ranitidine H2RA group
Esomeprazole  PPI group
Lansoprazole PPI group
Omeprazole PPI group
Pantoprazole PPI group
Rabeprazole PPI group
Pravastatin Statins group
Simvastatin Statins group
Atorvastatin Statins-HP group
Rosuvastatin Statins-HP group
Actions
Download as PDF Download as Word Document


Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0